Concepedia

Ema Požek

EP

Statistics

Publications

3

Citations

217

H-Index

3

Active since

2023

Affiliations

Universität Hamburg(Current)

Charité - Universitätsmedizin Berlin

German Cancer Research Center

Heidelberg University

Asklepios Klinik Altona

Ema Požek is an author at Universität Hamburg specializing in multiple myeloma therapy, hematologic malignancy therapy, and multiple myeloma.

Publications per year

2023–2024

3

Publications

3

Isatuximab, Carfilzomib, Lenalidomide, and Dexamethasone for the Treatment of High-Risk Newly Diagnosed Multiple Myeloma

Lisa Leypoldt, Diana Tichy, Britta Besemer et al. · Journal of Clinical Oncology · 2023 · 141 citations · Full text

, , +17

Isatuximab, Lenalidomide, Bortezomib, and Dexamethasone Induction Therapy for Transplant-Eligible Newly Diagnosed Multiple Myeloma: Final Part 1 Analysis of the GMMG-HD7 Trial

K. Elias, Uta Bertsch, Ema Požek et al. · Journal of Clinical Oncology · 2024 · 62 citations · Full text

, , +17

Measurable residual disease monitoring in AML with <i>FLT3</i>-ITD treated with intensive chemotherapy plus midostaurin

Frank G. Rücker, Lars Bullinger, Sibylle Cocciardi et al. · Blood Advances · 2024 · 14 citations · Full text

, , +13

1–3 of 3